NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Hyunkyung Kong
National Cancer Institute - / United States
Others
AD Scientific Index ID: 4396838
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Hyunkyung Kong's MOST POPULAR ARTICLES
1-)
Targeting of miR34a–NOTCH1 axis reduced breast cancer stemness and chemoresistanceEY Park, ES Chang, EJ Lee, HW Lee, HG Kang, KH Chun, YM Woo, ...Cancer research 74 (24), 7573-7582, 20141782014
2-)
Inhibition of aerobic glycolysis represses Akt/mTOR/HIF-1α axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cellsYM Woo, Y Shin, EJ Lee, S Lee, SH Jeong, HK Kong, EY Park, HK Kim, ...PloS one 10 (7), e0132285, 20151042015
3-)
A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancerEY Park, ES Chang, HG Kang, Y Koo, EJ Lee, JY Ko, HK Kong, KH Chun, ...Oncotarget 7 (12), 14791, 2016632016
4-)
miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancerD Son, Y Kim, S Lim, HG Kang, DH Kim, JW Park, W Cheong, HK Kong, ...Cancer letters 454, 224-233, 2019702019
5-)
Nuclear focal adhesion kinase controls vascular smooth muscle cell proliferation and neointimal hyperplasia through GATA4-mediated cyclin D1 transcriptionK Jeong, JH Kim, JM Murphy, H Park, SJ Kim, YAR Rodriguez, H Kong, ...Circulation Research 125 (2), 152-166, 2019672019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept